Alnylam Pharmaceuticals Pre-Paid Expenses 2010-2024 | ALNY

Alnylam Pharmaceuticals pre-paid expenses for the quarter ending December 31, 2024 were $0.117B, a 24.42% decline year-over-year.

  • Alnylam Pharmaceuticals pre-paid expenses for 2024 were $0.117B, a 0% decline from 2024.
  • Alnylam Pharmaceuticals pre-paid expenses for 2024 were $0.117B, a 7.45% decline from 2023.
  • Alnylam Pharmaceuticals pre-paid expenses for 2023 were $0.126B, a 0% decline from 2023.

Alnylam Pharmaceuticals Pre-Paid Expenses 2010-2024 | ALNY

  • Alnylam Pharmaceuticals pre-paid expenses for 2024 were $0.117B, a 0% decline from 2024.
  • Alnylam Pharmaceuticals pre-paid expenses for 2024 were $0.117B, a 7.45% decline from 2023.
  • Alnylam Pharmaceuticals pre-paid expenses for 2023 were $0.126B, a 0% decline from 2023.